Oral L-arginine supplementation in acute myocardial infarction therapy: A meta-analysis of randomized controlled trials

Clinical Cardiology

Volumn 32, Issue 11, 2009, Pages 649-652

  Sun, Tao ^a   Zhou, Wen Bai ^a   Luo, Xin Ping ^a   Tang, Yao Liang ^b   Shi, Hai Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b KECK GRADUATE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; HUMAN; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ARGININE; CARDIOVASCULAR AGENTS; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 73249118905     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20616     Document Type: Article

References (14)

1. World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
2. Perez-Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res. 2006;40(10):1054-1065.
3. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
4. Lerman A, Suwaidi JA, Velianou JL. L-arginine: a novel therapy for coronary artery disease? Expert Opin Investig Drugs. 1999;8(11): 1785-1793.
5. Tousoulis D, Böger RH, Antoniades C, Siasos G, Stefanadi E, Stefanadis C. Mechanisms of disease: L-arginine in coronary atherosclerosis-a clinical perspective. Nat Clin Pract Cardiovasc Med. 2007;4(5):274-283.
6. Stanislavov R, Nikolova V, Rohdewald P. Improvement of erectile function with Prelox: a randomized, double-blind, placebocontrolled, crossover trial. Int J Impot Res. 2008;20(2):173-180.
7. Miller AL. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Altern Med Rev. 2006;11(1):23-29.
8. Bai Y, Sun L, Yang T, Sun K, Chen J, Hui R. Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a metaanalysis of randomized controlled trials.AmJ Clin Nutr. 2009;89(1): 77-84.
9. Pernow J, Uriuda Y, Wang Q, Li X, Nordlander R, Rydeń L. The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J. 1994;15:1712-1719.
10. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609-613.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials. 1986;7:177-188.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
13. Bednarz B, Jaxa-Chamiec T, Maciejewski P, et al. Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. Kardiol Pol. 2005;62(5):421-427.
14. Schulman SP, Becker LC, Kass DA, et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295(1):58-64.